Hologic, Inc. Share Price
Stocks
HOLX
US4364401012
Advanced Medical Equipment & Technology
|
Market Closed -
Nasdaq
21:00:00 06/04/2026 BST
|
5-day change | 1st Jan Change | ||
| 76.01 USD | +0.48% |
|
-.--% | +2.04% |
| 07-30 | Quest Diagnostics And Hologic, Inc. Conduct National Health Trends Study On Bacterial Vaginosis And STI Co-Infection | CI |
| 06-30 | Hologic Recalls BioZorb Implantable Markers, FDA Says | MT |
| Market Cap | 16.97B 14.8B 13.97B 12.69B 23.77B 1,628B 23.87B 167B 64.58B 828B 63.74B 62.33B 2,664B | P/E 2024 |
24.3x | P/E 2025 | 27x |
|---|---|---|---|---|---|
| Enterprise Value | 17.39B 15.16B 14.32B 13B 24.36B 1,669B 24.46B 172B 66.19B 848B 65.32B 63.87B 2,730B | EV / Sales 2024 |
4.74x | EV / Sales 2025 | 3.75x |
| Free-Float |
73.08% | Yield 2024 * |
-
| Yield 2025 | - |
Last Transcript: Hologic, Inc.
| 1 day | +0.48% | ||
| 6 months | +1.14% | ||
| Current year | +2.04% |
| Current year | 74.49 |  | 76.07 |
| 1 year | 65 | | 76.07 |
| 3 years | 51.9 | | 84.67 |
| 5 years | 51.9 | | 87.88 |
| 10 years | 26.49 | | 87.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
Joe Almeida
CEO | Chief Executive Officer | 63 | 06/04/2026 |
Brian Montgomery
DFI | Director of Finance/CFO | - | 15/04/2026 |
Essex Mitchell
COO | Chief Operating Officer | 46 | 31/12/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Joe Almeida
BRD | Director/Board Member | 63 | 06/04/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 07/04/26 | Issuer sale | Director | 19,583 | 0.0088% | ||
| 07/04/26 | Issuer sale | General Counsel | 72,500 | 0.0325% | ||
| 07/04/26 | Issuer sale | Executive/Senior Manager | 123,246 | 0.0552% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.48% | -.--% | +11.34% | +5.57% | 16.97B | |
| -1.04% | +6.83% | +35.41% | +28.31% | 241B | |
| -0.32% | +5.83% | +8.47% | -16.53% | 149B | |
| +2.55% | +6.55% | -9.75% | +31.91% | 139B | |
| -0.48% | +0.84% | -55.88% | -18.23% | 62.81B | |
| +0.01% | +4.61% | +18.39% | +21.00% | 50.87B | |
| -1.69% | -1.20% | -20.18% | -16.57% | 48.21B | |
| +0.08% | +6.49% | +22.61% | +38.85% | 44.11B | |
| -1.88% | +3.25% | +37.62% | +54.22% | 41.42B | |
| -2.27% | +16.07% | +132.57% | +68.26% | 36.18B | |
| Average | -0.46% | +5.84% | +18.06% | +19.68% | 82.93B | |
| Weighted average by Cap. | -0.25% | +6.02% | +14.99% | +17.41% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 4.03B 3.51B 3.32B 3.01B 5.65B 387B 5.67B 39.75B 15.34B 197B 15.14B 14.8B 633B | 4.1B 3.58B 3.38B 3.07B 5.74B 393B 5.77B 40.44B 15.61B 200B 15.4B 15.06B 644B |
| Net income | 790M 688M 650M 590M 1.11B 75.76B 1.11B 7.79B 3B 38.52B 2.97B 2.9B 124B | 566M 493M 466M 423M 792M 54.28B 796M 5.58B 2.15B 27.6B 2.13B 2.08B 88.8B |
| Net Debt | 321M 280M 265M 240M 450M 30.83B 452M 3.17B 1.22B 15.67B 1.21B 1.18B 50.43B | 421M 367M 347M 315M 590M 40.39B 592M 4.15B 1.6B 20.53B 1.58B 1.55B 66.07B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- HOLX Stock
Select your edition
All financial news and data tailored to specific country editions
